IL1B and cardiovascular disorder: As an antagonist of IL-1β, IL-1Ra treatment has been highly neuroprotective experimentally [43], while endogenous levels of IL-1Ra have been elucidated to be upregulated and related to adverse outcome after cardiovascular disease and stroke [4, 5].